Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-012250
Filing Date
2025-02-12
Accepted
2025-02-12 17:00:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7271
2 EXHIBIT 1 tm255748d1_ex99-1.htm EX-99.1 37011
  Complete submission text file 0001104659-25-012250.txt   45995
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Subject) CIK: 0001357874 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90975 | Film No.: 25615843
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)